Queen's University Belfast
Centre for Public Health
School of Medicine, Dentistry and Biomedical Sciences
The NEPHSTROM study is a phase 1-2 trial to establish the safety and tolerability of a single intravenous infusion of stem cells in the treatment of patients with type II diabetes and progressive diabetic kidney disease. As part of the study an exploratory economic evaluation of the intervention will be conducted under the direction of Professor Ciaran O'Neill.
The successful candidate will undertake the development and analysis of a Marokovian model of the infusion of stem cells compared with a placebo within a cost-utility analysis. The model will be populated with data collected alongside the clinical trial, augmented as necessary with data from the literature. The study will examine costs, effects and provide an indicative cost-utility analysis of the intervention against a placebo provided in conjunction with usual care. The trial will be conducted in three European countries: Ireland, Italy and the UK. This post is available until 30 April 2019.
Anticipated interview date: Friday 10 November 2017
Salary scale: £32,548 - £36,613 per annum
Closing date: Tuesday 17 October 2017
The University is committed to equality of opportunity and to selection on merit. It therefore welcomes applications from all sections of society and particularly welcomes applications from people with a disability
Fixed term contract posts are available for the stated period in the first instance but in particular circumstances may be renewed or made permanent subject to availability of funding.
This job comes from a partnership with Science Magazine and